Ligand Pharmaceuticals Financials

Values in thousands	2026-09-30	2026-06-30	2026-03-31	2025-12-31
Revenue	$78,746	$63,693	$51,722	$59,666
Gross Profit	76,096	60,479	49,647	85,654
EBITDA	-44,094	72,519	-14,296	66,404
EBIT	-41,196	64,304	-22,512	56,780
Net Income	-28,485	48,508	-13,345	44,784
Net Change In Cash	78,746	63,693	51,722	59,666
Free Cash Flow	-27,733	23,992	48,463	45,835
Cash	55,958	1,006,702	115,077	174,927
Basic Shares	19,962	21,837	19,883	21,138

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$268,087	$167,133	$131,314	$196,245
Gross Profit	261,499	156,059	96,265	143,418
EBITDA	192,735	40,794	100,837	81,204
EBIT	158,960	5,555	64,316	37,810
Net Income	124,453	-4,032	52,154	-33,361
Net Change In Cash	268,087	167,133	131,314	196,245
Free Cash Flow	48,907	77,407	-4,272	119,927
Cash	174,927	72,307	22,954	45,006
Basic Shares	20,294	18,290	17,757	16,868